1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation
2024) In Cardiovascular Research(
- Contribution to journal › Article
- 2023
-
Mark
Invariant natural killer T cells and incidence of first-time coronary events : a nested case-control study
(
- Contribution to journal › Article
-
Mark
Plasma levels of CCL21, but not CCL19, independently predict future coronary events in a prospective population-based cohort
(
- Contribution to journal › Article
- 2019
-
Mark
Elevated circulating effector memory T cells but similar levels of regulatory T cells in patients with type 2 diabetes mellitus and cardiovascular disease
(
- Contribution to journal › Article
-
Mark
Activation of immune responses against the basement membrane component collagen type IV does not affect the development of atherosclerosis in ApoE-deficient mice
(
- Contribution to journal › Article
- 2018
-
Mark
IL-1R and MyD88 signalling in CD4+ T cells promote Th17 immunity and atherosclerosis
(
- Contribution to journal › Article
- 2015
-
Mark
Low Levels of IgM Antibodies against an Advanced Glycation Endproduct-Modified Apolipoprotein B100 Peptide Predict Cardiovascular Events in Nondiabetic Subjects.
(
- Contribution to journal › Article
- 2014
-
Mark
Induction of T helper 2 responses against human Apolipoprotein B100 does not affect atherosclerosis in ApoE-/- mice.
2014) In Cardiovascular Research(
- Contribution to journal › Article
- 2012
-
Mark
Increased Inflammation in Atherosclerotic Lesions of Diabetic Akita-LDLr(-/-) Mice Compared to Nondiabetic LDLr(-/-) Mice.
(
- Contribution to journal › Article
-
Mark
High levels of IgM against methylglyoxal-modified apolipoprotein B100 is associated with less coronary artery calcification in patients with type 2 diabetes.
(
- Contribution to journal › Article